VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Amgen Inc. vs IDEXX Laboratories, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Amgen Inc.
AMGN · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
IDEXX Laboratories, Inc.
IDXX · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into IDEXX Laboratories, Inc.'s moat claims, evidence, and risks.
View IDXX analysisComparison highlights
- Moat score gap: IDEXX Laboratories, Inc. leads (82 / 100 vs 70 / 100 for Amgen Inc.).
- Segment focus: Amgen Inc. has 3 segments (80.1% in Core Innovative Medicines); IDEXX Laboratories, Inc. has 4 segments (91.7% in Companion Animal Group).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Amgen Inc. has 5 moat types across 3 domains; IDEXX Laboratories, Inc. has 5 across 3.
Primary market context
Amgen Inc.
Core Innovative Medicines
Branded biopharmaceutical therapies for common diseases (bone health, inflammation, oncology, cardiovascular and other specialty areas)
Global
Payers, providers, and pharmacies
Drug developer/manufacturer
80.1%
IDEXX Laboratories, Inc.
Companion Animal Group
Veterinary diagnostics and practice management software for companion animals
Global
Veterinary practices, corporate veterinary groups, and reference laboratories
Diagnostics platform owner (in-clinic instruments + consumables) and reference lab/service provider; practice management software provider
91.7%
Side-by-side metrics
Moat coverage
Shared moat types
Amgen Inc. strengths
IDEXX Laboratories, Inc. strengths
Segment mix
Amgen Inc. segments
Full profile >Core Innovative Medicines
Competitive
Rare Disease Portfolio (Horizon + others)
Quasi-Monopoly
Biosimilars
Oligopoly
IDEXX Laboratories, Inc. segments
Full profile >Companion Animal Group
Oligopoly
Water Quality Products
Oligopoly
Livestock, Poultry and Dairy
Competitive
Other (OPTI Medical and out-licensing)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.